More specifically, enhanced PD-L1 expression goes along with poor prognostic features, such as an increased proliferation index, enlarged tumor size, absence of estrogen receptor (ER) and/or progesterone receptor (PR), Her2 positivity, and a high tumor grade [14]. This evidence concerns the gene ERBB2 and neoplasm.